1st Female Libido Treatment Approved By FDA
The U.S. Food and Drug Administration on Tuesday approved Sprout Pharmaceutical Inc.'s drug flibanserin, the first to treat low sexual desire in premenopausal women, amid controversy among scientists skeptical of its...To view the full article, register now.
Already a subscriber? Click here to view full article